Clinical trial
Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin…
NCT00387387 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00387387 |
|---|---|
| Title | Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) |
| Official title | An Open-Label, Pharmacokinetic Study of the Safety and Tolerability of Pazopanib in Combination With FOLFOX 6 or CapeOx in Subjects With Colorectal Cancer |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms, Colorectal |
| Intervention type | Drug |
| Interventions | Pazopanib, FOLFOX 6, CapeOx |
| Enrollment | 50 |
| Start date | Oct 20, 2006 |
| Primary completion | Aug 14, 2009 |
| Completion | Aug 14, 2009 |
| First posted | Oct 13, 2006 |
| Last update posted | Nov 17, 2017 |
| Countries | India, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: